Position in NVO
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$582,135
+$129,522 QoQ
Shares Held
12,143
-1.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#664
of 1,348 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Carson Advisory Inc. holds $6,148,880 across 8 Drug Manufacturers - General names. NVO ranks #4 (9.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
10,242 | $2,601,160 | |
| 2 | LLY |
ELI LILLY & Co
|
796 | $954,746 | |
| 3 | ABBV |
AbbVie Inc.
|
2,694 | $677,918 | |
| 4 | NVO |
Novo Nordisk A S
This page
|
12,143 | $582,135 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
3,768 | $476,049 | |
| 6 | MRK |
Merck & Co., Inc.
|
3,024 | $388,584 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,371 | $251,857 | |
| 8 | PFE |
Pfizer Inc
|
8,988 | $216,431 |
All Filings in NVO
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $582,135 | 12,143 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $452,613 | 12,316 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $613,002 | 12,048 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $675,479 | 12,173 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $310,451 | 4,498 | Shares | Sole | 2025-08-05 | |
| No filing history on record for this holder in this stock. | ||||||